193 related articles for article (PubMed ID: 15034230)
1. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m.
Beaumont M; Batéjat D; Coste O; Van Beers P; Colas A; Clère JM; Piérard C
Neuropsychobiology; 2004; 49(3):154-62. PubMed ID: 15034230
[TBL] [Abstract][Full Text] [Related]
2. Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude.
Beaumont M; Batéjat D; Piérard C; Van Beers P; Philippe M; Léger D; Savourey G; Jouanin JC
Sleep; 2007 Nov; 30(11):1527-33. PubMed ID: 18041485
[TBL] [Abstract][Full Text] [Related]
3. Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters.
Beaumont M; Goldenberg F; Lejeune D; Marotte H; Harf A; Lofaso F
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1864-9. PubMed ID: 8665047
[TBL] [Abstract][Full Text] [Related]
4. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
[TBL] [Abstract][Full Text] [Related]
6. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
7. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
8. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
9. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
[TBL] [Abstract][Full Text] [Related]
10. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
11. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
Whitmore JN; Fischer JR; Storm WF
Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
[TBL] [Abstract][Full Text] [Related]
12. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
[TBL] [Abstract][Full Text] [Related]
13. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
15. Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers.
Quera-Salva MA; McCann C; Boudet J; Frisk M; Borderies P; Meyer P
Br J Clin Pharmacol; 1994 Jun; 37(6):539-43. PubMed ID: 7917771
[TBL] [Abstract][Full Text] [Related]
16. The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation.
Hall-Porter JM; Schweitzer PK; Eisenstein RD; Ahmed HA; Walsh JK
J Clin Sleep Med; 2014 Jan; 10(1):27-34. PubMed ID: 24426817
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
[TBL] [Abstract][Full Text] [Related]
18. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
Fry J; Scharf M; Mangano R; Fujimori M
Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD.
Girault C; Muir JF; Mihaltan F; Borderies P; De La Giclais B; Verdure A; Samson-Dollfus D
Chest; 1996 Nov; 110(5):1203-11. PubMed ID: 8915222
[TBL] [Abstract][Full Text] [Related]
20. Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam.
Paul MA; Gray G; MacLellan M; Pigeau RA
Aviat Space Environ Med; 2004 Jun; 75(6):512-9. PubMed ID: 15198277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
